Timing of Initiation of Methadone Take-Home Dosing
Listen to this summary
The authors aimed to determine the impact of different initiation times for methadone take-home dosing on all-cause mortality and treatment discontinuation among individuals undergoing opioid use disorder treatment in British Columbia, Canada. Their findings indicate that initiating take-home doses within 5 to 12 weeks and 13 to 24 weeks after induction significantly reduced both mortality and discontinuation rates compared to no take-home dosing, highlighting the potential benefits of refining clinical guidelines for methadone treatment.
This is one of 33,000+ journals available on OSLR. Try it free for 14 days.
Free 14-day trial. 33,000+ journals. Cancel anytime.

More from JAMA internal medicine
View all →Sep 21, 2026 · JAMA internal medicine
Steatotic Liver Disease Risk Scores to Predict Cirrhosis and Hepatocellular Carcinoma
Sep 14, 2026 · JAMA internal medicine
Effective Palliative Care for Hospice Transitions
Sep 8, 2026 · JAMA internal medicine
Menopausal Hormone Therapy and Cardiovascular Risk in Midlife Women With Vasomotor Symptoms
Aug 31, 2026 · JAMA internal medicine
Respiratory Syncytial Virus Vaccine Effectiveness in Medicare Beneficiaries Residing in Nursing Homes
Aug 30, 2026 · JAMA internal medicine
Specialist Referral for Cardiovascular Risk in Patients With Prostate Cancer: A Randomized Clinical Trial
Aug 24, 2026 · JAMA internal medicine
Epidemiologic Study of Transfusion-Related Alpha-Gal Syndrome
More in Internal Medicine
View all →Sep 23, 2026 · JACC. Clinical electrophysiology
Programmed Ventricular Stimulation for Risk Stratification in Nonischemic Cardiomyopathy With Preserved or Mildly Reduced LVEF
Sep 23, 2026 · Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Five-Year Follow-Up of the Phase III ASCOT Trial of Adjuvant S-1 After Resection for Biliary Tract Cancer
Sep 23, 2026 · American journal of respiratory and critical care medicine
Biologic outcomes in severe asthma patients by smoking status: evidence from SHARP
Sep 23, 2026 · The New England journal of medicine
Effect of Screening with Multicancer Early-Detection Test on Late-Stage Cancer Diagnosis
Sep 23, 2026 · The New England journal of medicine
Phase 1 Study of Anito-cel, a d-Domain BCMA CAR T Cell for Refractory or Recurrent Myeloma
Sep 23, 2026 · American journal of respiratory and critical care medicine
Combined results of the TETON-1 and TETON-2 Trials of Inhaled Treprostinil for Idiopathic Pulmonary Fibrosis
"Oslr has become part of my weekly routine on my day off. The clinical relevance of the summaries is outstanding — I'd rate it 9/10. Being able to consume research hands-free is a huge advantage for busy physicians."
Dr. Jennifer Thompson
Portland, OR


